Beat-to-beat QT interval variability is primarily affected by the autonomic nervous system

Annals of Noninvasive Electrocardiology

Volumn 13, Issue 3, 2008, Pages 228-233

  Mine, Takanao ^a   Shimizu, Hiroki ^a   Hiromoto, Kenji ^b   Furukawa, Yoshio ^c   Kanemori, Tetsuzou ^a   Nakamura, Hiroaki ^a   Masuyama, Tohru ^a   Ohyanagi, Mitsumasa ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Takarazuka Municipal Hospital   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

Autonomic nervous system; QT interval; QT interval variability

Indexed keywords

ATROPINE; PROPRANOLOL;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; DRUG EFFECT; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; HEART RATE VARIABILITY; HUMAN; MALE; NERVE BLOCK; PRIORITY JOURNAL; QRS COMPLEX; QT INTERVAL; RR INTERVAL; T WAVE; TERAHERTZ SPECTROSCOPY;

AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; ATRIAL FLUTTER; ATROPINE; AUTONOMIC NERVOUS SYSTEM; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; PROPRANOLOL; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SICK SINUS SYNDROME; SURVIVAL RATE; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 47249152300     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2008.00225.x     Document Type: Article

References (19)

1. Alga A, Tijssen JG, Roelandt JR, et al. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991 83 : 1888 1894.
2. Berger RD, Kasper EK, Baughman KL, et al. Beat-to-beat QT interval variability, Novel evidence for repolarization liability in ischemic and nonischemic dilated cardiomyopathy. Circulation 1997 96 : 1557 1565.
3. Vrtovec B, Starc V, Sarc R. Beat-to-beat QT interval variability in coronary patients. J Electrocardiol 2000 33 : 119 125.
4. Atiga WL, Calkins H, Lawrence JH, et al. Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol 1998 9 : 899 908.
5. Murakawa Y, Inoue H, Nozaki A, et al. Role of sympathovagal interaction in diurnal variation of QT interval. Am J Cardiol 1992 62 : 339 343.
6. Browne KF, Zipes DP, Heger JJ, et al. Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol 1982 50 : 1099 1103.
7. Hiromoto K, Shimizu H, Mine T, et al. Correlation between beat-to-beat QT interval variability and impaired left ventricular function in patients with previous myocardial infarction. Ann Noninvasive Electrocardiol 2006 11 : 299 305.
8. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 1 : 307 310.
9. Browe KF, Prystowsky E, Heger JJ, et al. Prolongation of the Q-T interval in man during sleep. Am J Cardiol 1983 52 : 55 59.
10. Magnano AR, Holleran S, Ramakrishnan R, et al. Autonomic nervous system influences on QT interval in normal subjects. J Am Coll Cardiol 2002 39 : 1820 1826.
11. Emori T, Ohe T. Evaluation of direct respiratory modulation of the QT interval variability. Pace Clin Electrophysiol 1999 22 part I 742 748.
12. Lombardi F, Sandrone G, Porta A, et al. Spectral analysis of short term R-Tapex interval variability during sinus rhythm and fixed atrial rate. Eur Heart J 1996 17 : 769 778.
13. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II). A randomised trial. Lancet 1999 353 : 9 13.
14. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999 353 : 2001 2007.
15. Lechat P, Packer M, Chalon S, et al. Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 1998 98 : 1184 1191.
16. Johansson BW. Effect of beta blockade on ventricular fibrillation- and ventricular tachycardia-induced circulatory arrest in acute myocardial infarction. Am J Cardiol 1986 57 : 34F 37F.
17. Billman GE, Castillo LC, Hensley J, et al. Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: In vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death. Circulation 1997 96 : 1914 1922.
18. Mesqiuta ET, Deus FC, Guedes CR, et al. Effects of propranolol on the QT dispersion in congestive heart failure. Arq Bras Cardiol 1999 73 : 295 298.
19. Mesquita ET, Deus FC, Guedes CR, et al. Effects of propranolol on the QT dispersion in congestive heart failure. Arq Bras Cardiol 1999 73 : 291 298.